116 results
8-K
EX-3.1
TEVA
Teva- Pharmaceutical Industries Ltd.
23 Jun 22
Amendments to Articles of Incorporation or Bylaws
4:02pm
in surplus assets or otherwise with special rights or without special rights, including with or without voting rights.
The Company shall
424B5
937pm7grlo9z90
4 Nov 21
Prospectus supplement for primary offering
4:41pm
424B3
u5p4swhlfa914ef18g
27 Oct 21
Prospectus supplement
8:51am
S-3ASR
g3prpc3 782dw
27 Oct 21
Automatic shelf registration
7:42am
8-K
EX-3.1
11f73gc
9 Jun 20
Departure of Directors or Certain Officers
4:16pm
PRE 14A
9t5 7384sdfkye
19 Mar 20
Preliminary proxy
4:19pm
8-K
EX-10.1
zp3w1mg8mcu
10 Apr 19
Entry into a Material Definitive Agreement
8:01am
8-K
EX-3.2
iw5v0o
14 Dec 18
Material Modifications to Rights of Security Holders
7:51am
8-K
EX-3.3
40bilfrvk65vzs 8cu
14 Dec 18
Material Modifications to Rights of Security Holders
7:51am
8-K
EX-4.1
vrn1r92e61tqb5
4 Dec 18
Material Modifications to Rights of Security Holders
4:24pm
F-6
EX-99
h196ee
13 Nov 18
Registration for ADRs (foreign)
4:25pm